We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$3.17B
AUM Growth
+$1.84B
Cap. Flow
+$1.59B
Cap. Flow %
50.05%
Top 10 Hldgs %
25.88%
Holding
941
New
398
Increased
483
Reduced
23
Closed
10

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$74.8M
2
NVDA icon
NVIDIA
NVDA
+$66.1M
3
AAPL icon
Apple
AAPL
+$49.9M
4
AMZN icon
Amazon
AMZN
+$46.4M
5
META icon
Meta Platforms (Facebook)
META
+$31.7M

Sector Composition

Rank Sector Weight
1 Technology 23.33%
2 Financials 14.81%
3 Healthcare 9.6%
4 Industrials 7.93%
5 Communication Services 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
251
PepsiCo
PEP
$190B
$2.4M 0.08%
18,142
+7,613
+72% +$1.03M
KKR icon
252
KKR & Co
KKR
$92.3B
$2.39M 0.08%
17,984
+13,353
+288% +$1.56M
ELAN icon
253
Elanco Animal Health
ELAN
$11.1B
$2.37M 0.07%
166,198
+117,174
+239% +$1.37M
PH icon
254
Parker-Hannifin
PH
$135B
$2.32M 0.07%
3,323
+2,232
+205% +$1.41M
ING icon
255
ING
ING
$102B
$2.29M 0.07%
104,735
+44,960
+75% +$908K
SCHX icon
256
Schwab US Large- Cap ETF
SCHX
$74.6B
$2.27M 0.07%
93,000
BRO icon
257
Brown & Brown
BRO
$23.9B
$2.27M 0.07%
20,461
+13,391
+189% +$1.5M
SPEM icon
258
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$2.27M 0.07%
+53,031
New +$2.14M
RMD icon
259
ResMed
RMD
$30.7B
$2.25M 0.07%
8,740
+2,023
+30% +$483K
MUSA icon
260
Murphy USA
MUSA
$9.61B
$2.22M 0.07%
5,461
+2,610
+92% +$1.19M
KLAC icon
261
KLA
KLAC
$259B
$2.21M 0.07%
24,670
+17,960
+268% +$1.35M
EMR icon
262
Emerson Electric
EMR
$88.3B
$2.18M 0.07%
16,333
+9,333
+133% +$1.07M
RACE icon
263
Ferrari
RACE
$72.5B
$2.15M 0.07%
4,378
+1,615
+58% +$750K
AIG icon
264
American International
AIG
$41.3B
$2.12M 0.07%
24,782
+18,639
+303% +$1.55M
PYPL icon
265
PayPal
PYPL
$50.5B
$2.12M 0.07%
28,481
+18,475
+185% +$1.27M
MSCI icon
266
MSCI
MSCI
$40.9B
$2.09M 0.07%
3,627
+1,747
+93% +$967K
DXCM icon
267
DexCom
DXCM
$32B
$2.08M 0.07%
23,832
+16,443
+223% +$1.29M
TTD icon
268
Trade Desk
TTD
$6.49B
$2.07M 0.07%
28,814
+20,772
+258% +$1.33M
MFG icon
269
Mizuho Financial
MFG
$130B
$2.07M 0.07%
371,418
+224,675
+153% +$1.17M
ADSK icon
270
Autodesk
ADSK
$52.6B
$2.05M 0.06%
6,623
+4,782
+260% +$1.36M
LCII icon
271
LCI Industries
LCII
$2.65B
$2.05M 0.06%
+22,436
New +$1.91M
EBAY icon
272
eBay
EBAY
$49.8B
$2.03M 0.06%
27,311
+20,928
+328% +$1.48M
DUK icon
273
Duke Energy
DUK
$97.3B
$2.03M 0.06%
17,216
+9,017
+110% +$1.06M
GD icon
274
General Dynamics
GD
$106B
$2.01M 0.06%
6,908
+3,863
+127% +$1.06M
TDG icon
275
TransDigm Group
TDG
$67.7B
$1.98M 0.06%
1,302
+727
+126% +$1.02M

Similar funds

Callan Family Office's Q2 2025 Portfolio in Review

As of Q2 2025, Callan Family Office held 941 positions worth $3.17B, up 138% from $1.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Callan Family Office deployed $1.59B of net new capital in Q2 2025, opening 398 new positions and adding to 483 existing holdings. Its largest new stake was Fortive: 72,724 shares worth $3.79M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $1.79M trimmed.

  • Callan Family Office's largest Q2 2025 buy was Fortive: 72,724 shares worth $3.79M.
  • Callan Family Office added most to Microsoft in Q2 2025, an estimated $74.8M increase.
  • Callan Family Office's biggest Q2 2025 reduction was iShares Russell 1000 Value ETF, cutting an estimated $1.79M.
  • Callan Family Office fully exited Discover Financial Services in Q2 2025, selling an estimated $2.79M.
  • Callan Family Office's ten largest holdings make up 26% of its $3.17B portfolio in Q2 2025.
  • Callan Family Office opened 398 new positions and closed 10 in Q2 2025.
  • Callan Family Office's portfolio value rose 138% quarter-over-quarter to $3.17B.

Based on Callan Family Office's 13F filing for Q2 2025, filed 24 Jul 2025.